default author photo

Meliawati Poniman

University of Amsterdam - Department of Medical Microbiology and Infection Prevention

Amsterdam

Netherlands

SCHOLARLY PAPERS

3

DOWNLOADS

189

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Time Since SARS-CoV-2 Infection and Humoral Immune Response Following BNT162b2 mRNA Vaccination

Number of pages: 14 Posted: 12 May 2021
University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Medical Microbiology, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Independent, University of Amsterdam - Department of Intensive Care, University of Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, VU University Amsterdam - Department of Internal Medicine and VU University Amsterdam - Department of Internal Medicine
Downloads 109 (645,052)
Citation 1

Abstract:

Loading...

2.

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Number of pages: 42 Posted: 24 Nov 2020
University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Life and Soft, Institut Cochin, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Department of Viroscience, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Washington - Department of Biochemistry, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), AIMM Therapeutics BV, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Erasmus Medical Center - Viroscience Department, University of Amsterdam - Amsterdam Public Health Research Institute, Life and Soft, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Washington - Department of Biochemistry, University of Paris-Saclay - Molecular Genetics of RNA Viruses, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Amsterdam - Department of Medical Microbiology
Downloads 51 (1,052,702)

Abstract:

Loading...

SARS-CoV-2 vaccine, Self-assembling protein nanoparticle vaccine, SARS-CoV-2 NHP challenge study

3.

Recent Infection With HCoV-OC43 Is Associated With Protection Against Sars-Cov-2 Infection

Number of pages: 32 Posted: 23 Mar 2022
VU University Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Center for Experimental and Molecular Medicine, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, VU University Amsterdam - Department of Internal Medicine, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology and Infection Prevention and VU University Amsterdam - Department of Internal Medicine
Downloads 29 (1,332,057)

Abstract:

Loading...

Coronavirus, antibodies, OC43, NL63, HKU1, 229E, SARS-CoV-2, COVID-19